How Is the Government Shutdown Impacting Medtech?
FDA cannot accept new 2019 user fees during the government shutdown, which means the agency cannot accept new medical product applications.
Making Injection Molding More Efficient
Thanks to a new validation and part process, molders can now replicate transferable plastic conditions that can save millions of dollars a year and reduce machine downtime.
8 Medtech Manufacturing Trends You Need to Know
The manufacturing industry is on an upward growth trajectory, fueled by a strong economy and steady demand for products. But the $6.2 trillion industry is also faced with a host of challenges that are making it tough for companies to recruit and retain a sufficient workforce. A new report from Aerotek, a recruitment and staffing agency based in Hanover, MD, points to several modern manufacturing trends that are creating a hiring dilemma across the industry, including in the medical device sector. According to the report, companies are adjusting to these obstacles by making workforce plans for a future that could look very different.
Obalon Scores Funding on the Heels of Obesity Market Shift
The obesity treatment market has been through some changes lately and Obalon’s new funding deals could help the company navigate through some of these shifts and keep competitors at bay.
Edwards Heats up TAVR Market with New Approval
FDA’s nod for the Sapien 3 Ultra valve comes at a time when the TAVR market is heating up with competition.
Latest Boston Sci Deal Shakes up Mitral Repair Market
The Marlborough, MA-based company strengthens its structural heart portfolio and gains a deeper foothold in a market where Medtronic, Abbott Laboratories, and Edwards Lifesciences have already made significant acquisitions.
Alcon’s Acquisition Is a Real Tear-Jerker
Alcon acquired Tear Film Innovations, a company that makes a device to treat a leading cause of dry eye.
How Boston Scientific Reinvented Itself in 2018
Boston Scientific is Editor’s Choice for 2018 Company of the Year because of its numerous acquisitions, meticulous planning, and its unwillingness to stay silent when tackling controversy. The Marlborough, MA-based company is on the cusp of change.
Essure Discontinuation Doesn’t Mean the End to FDA Scrutiny
Bayer has already decided to stop selling the controversial birth control device, but FDA says it will continue to monitor the long-term safety of Essure.
Predict and Prevent: The Emergence of Real-Time Sensor-Based Care
Wearables are being used for everything from smoking cessation to epilepsy management.
